Emergent BioSolutions to lay off 400 as its scales back its contract manufacturing business


The company aims to save more than $100 million annually with the move.

Previous Clinical trial company Charter Research plans Orlando office near downtown along with hiring spree
Next Soft life sciences sector reflects Triangle's flex space challenges